(LYNCHBURG, Va. – Feb. 25, 2020) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully labeled technetium-99m (Tc-99m) derived …
(LYNCHBURG, Va. – Feb. 25, 2020) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully labeled technetium-99m (Tc-99m) derived …
(LYNCHBURG, Va. – October 30, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it plans to produce the medical radioisotope …
(LYNCHBURG, Va. – September 26, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT ITG Canada, Inc., having received …
(LYNCHBURG, Va. – July 12, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that a subsidiary has signed an agreement with Bruce …
LYNCHBURG, Va. – BWX Technologies, Inc. is expanding its longstanding relationship with Ontario Power Generation (OPG), whose wholly owned subsidiary Canadian Nuclear …
BWX Technologies, Inc. announced today that it has developed an innovative and unique process to manufacture molybdenum-99 (Mo-99) that will enable a stable, North American supply of this critical diagnostic imaging radionuclide.
Community Inquiries:
Phone: 1.833.657.4565
email: [email protected]
Job Seekers:
Please visit www.bwxt.com/careers
for current opportunities.
For urgent media inquiries, please contact:
Monifa Miller
Senior Director, Corporate Affairs
+1 519.242.8071
[email protected]